185 related articles for article (PubMed ID: 16040263)
1. Myoadenylate deaminase deficiency caused by alternative splicing due to a novel intronic mutation in the AMPD1 gene.
Isackson PJ; Bujnicki H; Harding CO; Vladutiu GD
Mol Genet Metab; 2005; 86(1-2):250-6. PubMed ID: 16040263
[TBL] [Abstract][Full Text] [Related]
2. In vitro splicing analysis showed that availability of a cryptic splice site is not a determinant for alternative splicing patterns caused by +1G-->A mutations in introns of the dystrophin gene.
Habara Y; Takeshima Y; Awano H; Okizuka Y; Zhang Z; Saiki K; Yagi M; Matsuo M
J Med Genet; 2009 Aug; 46(8):542-7. PubMed ID: 19001018
[TBL] [Abstract][Full Text] [Related]
3. Mutation analysis and characterization of ATR sequence variants in breast cancer cases from high-risk French Canadian breast/ovarian cancer families.
Durocher F; Labrie Y; Soucy P; Sinilnikova O; Labuda D; Bessette P; Chiquette J; Laframboise R; Lépine J; Lespérance B; Ouellette G; Pichette R; Plante M; Tavtigian SV; Simard J
BMC Cancer; 2006 Sep; 6():230. PubMed ID: 17010193
[TBL] [Abstract][Full Text] [Related]
4. N34S mutation in the SPINK1 gene is not associated with alternative splicing.
Masamune A; Kume K; Takagi Y; Kikuta K; Satoh K; Satoh A; Shimosegawa T
Pancreas; 2007 May; 34(4):423-8. PubMed ID: 17446841
[TBL] [Abstract][Full Text] [Related]
5. A novel SLC12A3 splicing mutation skipping of two exons and preliminary screening for alternative splice variants in human kidney.
Shao L; Liu L; Miao Z; Ren H; Wang W; Lang Y; Yue S; Chen N
Am J Nephrol; 2008; 28(6):900-7. PubMed ID: 18580052
[TBL] [Abstract][Full Text] [Related]
6. The cytochrome P450 aromatase lacking exon 5 is associated with a phenotype of nonclassic aromatase deficiency and is also present in normal human steroidogenic tissues.
Pepe CM; Saraco NI; Baquedano MS; Guercio G; Vaiani E; Marino R; Pandey AV; Flück CE; Rivarola MA; Belgorosky A
Clin Endocrinol (Oxf); 2007 Nov; 67(5):698-705. PubMed ID: 17608756
[TBL] [Abstract][Full Text] [Related]
7. Persistent Mullerian duct syndrome caused by both a 27-bp deletion and a novel splice mutation in the MIS type II receptor gene.
Hoshiya M; Christian BP; Cromie WJ; Kim H; Zhan Y; MacLaughlin DT; Donahoe PK
Birth Defects Res A Clin Mol Teratol; 2003 Oct; 67(10):868-74. PubMed ID: 14745940
[TBL] [Abstract][Full Text] [Related]
8. Two alternative exons can result from activation of the cryptic splice acceptor site deep within intron 2 of the dystrophin gene in a patient with as yet asymptomatic dystrophinopathy.
Yagi M; Takeshima Y; Wada H; Nakamura H; Matsuo M
Hum Genet; 2003 Feb; 112(2):164-70. PubMed ID: 12522557
[TBL] [Abstract][Full Text] [Related]
9. Functional characterization of the novel mutation IVS 8 (-11delC) (-14T>A) in the intron 8 of the glucocerebrosidase gene of two Italian siblings with Gaucher disease type I.
Romano M; Danek GM; Baralle FE; Mazzotti R; Filocamo M
Blood Cells Mol Dis; 2000 Jun; 26(3):171-6. PubMed ID: 10950936
[TBL] [Abstract][Full Text] [Related]
10. First missense mutations (R388W and R425H) of AMPD1 accompanied with myopathy found in a Japanese patient.
Morisaki H; Higuchi I; Abe M; Osame M; Morisaki T
Hum Mutat; 2000 Dec; 16(6):467-72. PubMed ID: 11102975
[TBL] [Abstract][Full Text] [Related]
11. Alport syndrome. Molecular genetic aspects.
Hertz JM
Dan Med Bull; 2009 Aug; 56(3):105-52. PubMed ID: 19728970
[TBL] [Abstract][Full Text] [Related]
12. Molecular biology of AMP deaminase deficiency.
Gross M
Pharm World Sci; 1994 Apr; 16(2):55-61. PubMed ID: 8032342
[TBL] [Abstract][Full Text] [Related]
13. Selective IgG2 deficiency due to a point mutation causing abnormal splicing of the Cgamma2 gene.
Zhao Y; Pan-Hammarström Q; Zhao Z; Wen S; Hammarström L
Int Immunol; 2005 Jan; 17(1):95-101. PubMed ID: 15569770
[TBL] [Abstract][Full Text] [Related]
14. A point mutation in the 5' splice region of intron 7 causes a deletion of exon 7 in adenosine deaminase mRNA.
Kawamoto H; Ito K; Kashii S; Monden S; Fujita M; Norioka M; Sasai Y; Okuma M
J Cell Biochem; 1993 Mar; 51(3):322-5. PubMed ID: 8501134
[TBL] [Abstract][Full Text] [Related]
15. Alternative splicing: a mechanism for phenotypic rescue of a common inherited defect.
Morisaki H; Morisaki T; Newby LK; Holmes EW
J Clin Invest; 1993 May; 91(5):2275-80. PubMed ID: 8486786
[TBL] [Abstract][Full Text] [Related]
16. Does the C34T mutation in AMPD1 alter exercise capacity in the elderly?
Pérez M; Martin MA; Cañete S; Rubio JC; Fernández-Moreira D; San Juan AF; Gómez-Gallego F; Santiago C; Arenas J; Lucia A
Int J Sports Med; 2006 Jun; 27(6):429-35. PubMed ID: 16767606
[TBL] [Abstract][Full Text] [Related]
17. Alternative splicing of Rh blood group polypeptide mRNA produces a novel transcript containing a short nucleotide insertion on human erythroleukemia K562 cells.
Sakata N; Yamazaki K; Kogure T; Mukai T
Cell Biol Int; 2001; 25(7):697-703. PubMed ID: 11448109
[TBL] [Abstract][Full Text] [Related]
18. Positive and negative elements mediate control of alternative splicing in the AMPD1 gene.
Morisaki H; Morisaki T; Kariko K; Genetta T; Holmes EW
Gene; 2000 Apr; 246(1-2):365-72. PubMed ID: 10767559
[TBL] [Abstract][Full Text] [Related]
19. Acetylcholinesterase (AChE) gene modification in transgenic animals: functional consequences of selected exon and regulatory region deletion.
Camp S; Zhang L; Marquez M; de la Torre B; Long JM; Bucht G; Taylor P
Chem Biol Interact; 2005 Dec; 157-158():79-86. PubMed ID: 16289062
[TBL] [Abstract][Full Text] [Related]
20. Functional analysis of splicing mutations and of an exon 2 polymorphic variant of SERPING1/C1NH.
Duponchel C; Djenouhat K; Frémeaux-Bacchi V; Monnier N; Drouet C; Tosi M
Hum Mutat; 2006 Mar; 27(3):295-6. PubMed ID: 16470590
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
